Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Epilepsy | 45 | 2021 | 1401 | 7.83 | Why? |
| Anticonvulsants | 22 | 2019 | 634 | 5.45 | Why? |
| Seizures | 17 | 2020 | 1163 | 3.73 | Why? |
| Death, Sudden | 8 | 2019 | 160 | 2.86 | Why? |
| Drug Resistant Epilepsy | 5 | 2019 | 106 | 2.73 | Why? |
| Neurocysticercosis | 2 | 2018 | 51 | 1.37 | Why? |
| Mortality, Premature | 2 | 2018 | 111 | 1.28 | Why? |
| Pyridones | 4 | 2018 | 738 | 1.12 | Why? |
| Intellectual Disability | 4 | 2018 | 391 | 1.04 | Why? |
| Sclerosis | 2 | 2018 | 26 | 0.82 | Why? |
| Hippocampus | 2 | 2018 | 237 | 0.77 | Why? |
| Myoclonic Epilepsy, Juvenile | 1 | 2018 | 1 | 0.76 | Why? |
| Dibenzazepines | 1 | 2018 | 2 | 0.75 | Why? |
| Voltage-Gated Sodium Channel Blockers | 1 | 2018 | 29 | 0.73 | Why? |
| Diet, Ketogenic | 2 | 2017 | 109 | 0.72 | Why? |
| Parasitic Diseases | 1 | 2019 | 84 | 0.70 | Why? |
| Guanidinoacetate N-Methyltransferase | 1 | 2017 | 2 | 0.70 | Why? |
| Epilepsy, Temporal Lobe | 4 | 2018 | 37 | 0.69 | Why? |
| Marriage | 1 | 2018 | 83 | 0.69 | Why? |
| Language Development Disorders | 1 | 2017 | 10 | 0.69 | Why? |
| Vagus Nerve | 1 | 2017 | 57 | 0.65 | Why? |
| Methylation | 1 | 2017 | 332 | 0.64 | Why? |
| Acidosis | 1 | 2017 | 125 | 0.62 | Why? |
| Vagus Nerve Stimulation | 1 | 2017 | 77 | 0.62 | Why? |
| Transcranial Magnetic Stimulation | 1 | 2017 | 160 | 0.60 | Why? |
| Breathing Exercises | 1 | 2017 | 118 | 0.59 | Why? |
| Rural Population | 2 | 2019 | 2408 | 0.59 | Why? |
| Drug Substitution | 1 | 2018 | 385 | 0.55 | Why? |
| Movement Disorders | 1 | 2017 | 186 | 0.55 | Why? |
| Phenobarbital | 1 | 2012 | 22 | 0.51 | Why? |
| Checklist | 1 | 2018 | 714 | 0.47 | Why? |
| Acetamides | 1 | 2013 | 141 | 0.46 | Why? |
| Carbamazepine | 4 | 2017 | 34 | 0.44 | Why? |
| Mindfulness | 1 | 2017 | 437 | 0.43 | Why? |
| Neuroimaging | 1 | 2018 | 1106 | 0.43 | Why? |
| Health Services | 1 | 2017 | 765 | 0.42 | Why? |
| Risk Management | 1 | 2018 | 1044 | 0.41 | Why? |
| Taenia solium | 2 | 2019 | 26 | 0.38 | Why? |
| Electroencephalography | 6 | 2018 | 1242 | 0.38 | Why? |
| Medication Adherence | 2 | 2017 | 1270 | 0.36 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 1261 | 0.34 | Why? |
| Epilepsies, Partial | 2 | 2017 | 44 | 0.32 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.32 | Why? |
| Poverty | 1 | 2018 | 2302 | 0.31 | Why? |
| Circadian Rhythm | 1 | 2011 | 607 | 0.30 | Why? |
| Nitriles | 4 | 2018 | 1053 | 0.30 | Why? |
| Nervous System Diseases | 2 | 2021 | 4092 | 0.29 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.28 | Why? |
| Caregivers | 2 | 2020 | 3112 | 0.27 | Why? |
| Tertiary Care Centers | 2 | 2018 | 8248 | 0.25 | Why? |
| Adult | 38 | 2020 | 244371 | 0.25 | Why? |
| Humans | 67 | 2021 | 930598 | 0.24 | Why? |
| Valproic Acid | 2 | 2018 | 114 | 0.21 | Why? |
| Communication | 1 | 2018 | 5206 | 0.21 | Why? |
| Gliosis | 1 | 2019 | 16 | 0.20 | Why? |
| Taeniasis | 1 | 2019 | 9 | 0.20 | Why? |
| Consciousness | 1 | 2021 | 140 | 0.20 | Why? |
| Surveys and Questionnaires | 5 | 2020 | 43792 | 0.19 | Why? |
| Parasites | 1 | 2019 | 39 | 0.19 | Why? |
| Water-Electrolyte Imbalance | 1 | 2020 | 119 | 0.19 | Why? |
| Receptors, GABA-A | 1 | 2018 | 15 | 0.19 | Why? |
| Epilepsy, Generalized | 1 | 2018 | 16 | 0.19 | Why? |
| Benzodiazepines | 2 | 2017 | 163 | 0.19 | Why? |
| Sleep | 1 | 2011 | 2695 | 0.18 | Why? |
| Phenytoin | 1 | 2017 | 17 | 0.18 | Why? |
| Treatment Outcome | 13 | 2020 | 51732 | 0.18 | Why? |
| Apolipoproteins | 1 | 2017 | 33 | 0.18 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.17 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 8811 | 0.17 | Why? |
| Adolescent | 19 | 2020 | 86841 | 0.17 | Why? |
| Ketone Bodies | 1 | 2017 | 53 | 0.17 | Why? |
| Young Adult | 20 | 2020 | 93724 | 0.17 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.17 | Why? |
| Vigabatrin | 2 | 2017 | 44 | 0.17 | Why? |
| Caffeine | 1 | 2018 | 67 | 0.17 | Why? |
| Brain Waves | 1 | 2017 | 37 | 0.17 | Why? |
| Ketosis | 1 | 2017 | 44 | 0.17 | Why? |
| Creatine | 1 | 2017 | 66 | 0.17 | Why? |
| Functional Laterality | 1 | 2017 | 57 | 0.17 | Why? |
| Serotonin Uptake Inhibitors | 1 | 2018 | 149 | 0.16 | Why? |
| Granuloma | 1 | 2017 | 88 | 0.16 | Why? |
| Central Nervous System Stimulants | 1 | 2018 | 111 | 0.16 | Why? |
| Disease Resistance | 1 | 2019 | 236 | 0.16 | Why? |
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 187 | 0.16 | Why? |
| Male | 37 | 2021 | 367725 | 0.16 | Why? |
| Dietary Fats | 1 | 2017 | 96 | 0.16 | Why? |
| Models, Neurological | 1 | 2017 | 121 | 0.16 | Why? |
| Causality | 1 | 2020 | 857 | 0.16 | Why? |
| Temporal Lobe | 1 | 2017 | 83 | 0.16 | Why? |
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2017 | 82 | 0.16 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.16 | Why? |
| Hydrocortisone | 2 | 2017 | 1790 | 0.16 | Why? |
| Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 279 | 0.15 | Why? |
| Retrospective Studies | 17 | 2021 | 105322 | 0.15 | Why? |
| Family Health | 2 | 2018 | 731 | 0.15 | Why? |
| Nonlinear Dynamics | 1 | 2017 | 177 | 0.15 | Why? |
| Whole Exome Sequencing | 1 | 2018 | 437 | 0.15 | Why? |
| Substance Withdrawal Syndrome | 1 | 2018 | 137 | 0.15 | Why? |
| Biological Availability | 1 | 2017 | 388 | 0.15 | Why? |
| Motor Activity | 1 | 2017 | 217 | 0.15 | Why? |
| Memory Disorders | 1 | 2017 | 190 | 0.15 | Why? |
| Middle Aged | 30 | 2021 | 270681 | 0.15 | Why? |
| Female | 35 | 2021 | 380317 | 0.15 | Why? |
| Residential Facilities | 1 | 2020 | 443 | 0.15 | Why? |
| Autonomic Nervous System | 1 | 2017 | 148 | 0.14 | Why? |
| Risk Factors | 11 | 2020 | 71621 | 0.14 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.14 | Why? |
| Central Nervous System Diseases | 1 | 2020 | 410 | 0.14 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.14 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.14 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2018 | 319 | 0.14 | Why? |
| Child Development | 1 | 2018 | 352 | 0.13 | Why? |
| Depression | 1 | 2018 | 14116 | 0.13 | Why? |
| Cerebral Cortex | 1 | 2017 | 276 | 0.13 | Why? |
| Genetic Variation | 2 | 2018 | 3919 | 0.13 | Why? |
| Child | 12 | 2020 | 70012 | 0.13 | Why? |
| Drug Eruptions | 1 | 2017 | 319 | 0.12 | Why? |
| Blood-Brain Barrier | 1 | 2017 | 531 | 0.12 | Why? |
| Positron-Emission Tomography | 1 | 2018 | 802 | 0.12 | Why? |
| Hyponatremia | 1 | 2017 | 371 | 0.12 | Why? |
| Follow-Up Studies | 5 | 2018 | 17020 | 0.12 | Why? |
| Optic Nerve Diseases | 1 | 2012 | 40 | 0.12 | Why? |
| Nerve Fibers | 1 | 2012 | 73 | 0.12 | Why? |
| Africa South of the Sahara | 1 | 2017 | 1335 | 0.12 | Why? |
| Migraine Disorders | 1 | 2019 | 530 | 0.12 | Why? |
| Retinal Ganglion Cells | 1 | 2012 | 80 | 0.12 | Why? |
| Insurance, Health | 1 | 2017 | 634 | 0.12 | Why? |
| Optic Disk | 1 | 2012 | 66 | 0.12 | Why? |
| Incidence | 5 | 2020 | 25622 | 0.11 | Why? |
| Age of Onset | 1 | 2013 | 557 | 0.11 | Why? |
| Kaplan-Meier Estimate | 3 | 2018 | 4260 | 0.11 | Why? |
| Cohort Studies | 8 | 2020 | 36005 | 0.11 | Why? |
| Psychiatric Status Rating Scales | 1 | 2018 | 1340 | 0.11 | Why? |
| Drug Resistance | 1 | 2013 | 395 | 0.11 | Why? |
| Prevalence | 4 | 2020 | 25773 | 0.10 | Why? |
| Aged | 17 | 2020 | 215776 | 0.10 | Why? |
| Income | 1 | 2018 | 1564 | 0.09 | Why? |
| Global Health | 1 | 2012 | 13911 | 0.09 | Why? |
| Heart Ventricles | 1 | 2017 | 1139 | 0.09 | Why? |
| Long-Term Care | 1 | 2020 | 2047 | 0.09 | Why? |
| China | 7 | 2020 | 50654 | 0.09 | Why? |
| Child, Preschool | 7 | 2020 | 36283 | 0.09 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.08 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.08 | Why? |
| Treatment Failure | 1 | 2013 | 2106 | 0.08 | Why? |
| Pregnancy Complications | 1 | 2018 | 1388 | 0.08 | Why? |
| Heart Arrest | 1 | 2017 | 1239 | 0.08 | Why? |
| Depressive Disorder | 1 | 2017 | 1236 | 0.08 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.07 | Why? |
| Periodicals as Topic | 1 | 2018 | 1492 | 0.07 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.07 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.07 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.07 | Why? |
| United Kingdom | 3 | 2020 | 18046 | 0.07 | Why? |
| Stroke | 2 | 2018 | 8839 | 0.07 | Why? |
| Suicide | 1 | 2017 | 1500 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.07 | Why? |
| Case-Control Studies | 4 | 2018 | 17671 | 0.07 | Why? |
| Survival Analysis | 2 | 2017 | 7592 | 0.07 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.06 | Why? |
| Drug Therapy, Combination | 2 | 2017 | 7268 | 0.06 | Why? |
| Stress, Psychological | 2 | 2017 | 10231 | 0.06 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.06 | Why? |
| Fatty Acids, Omega-3 | 1 | 2005 | 306 | 0.06 | Why? |
| Vision Disorders | 2 | 2017 | 260 | 0.06 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.05 | Why? |
| Glasgow Coma Scale | 1 | 2021 | 249 | 0.05 | Why? |
| Animals | 3 | 2019 | 78931 | 0.05 | Why? |
| Parents | 1 | 2014 | 2758 | 0.05 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.05 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.05 | Why? |
| Brain | 1 | 2017 | 5133 | 0.05 | Why? |
| World Health Organization | 1 | 2012 | 4213 | 0.05 | Why? |
| Longitudinal Studies | 3 | 2020 | 9893 | 0.05 | Why? |
| Alpha Rhythm | 1 | 2017 | 9 | 0.05 | Why? |
| Infant | 5 | 2020 | 30274 | 0.05 | Why? |
| Cyclohexanecarboxylic Acids | 1 | 2017 | 15 | 0.04 | Why? |
| Complement Factor H | 1 | 2017 | 83 | 0.04 | Why? |
| Residential Treatment | 1 | 2018 | 61 | 0.04 | Why? |
| Registries | 1 | 2018 | 12327 | 0.04 | Why? |
| Lethargy | 1 | 2017 | 55 | 0.04 | Why? |
| Pregabalin | 1 | 2017 | 22 | 0.04 | Why? |
| Amines | 1 | 2017 | 67 | 0.04 | Why? |
| gamma-Aminobutyric Acid | 1 | 2017 | 52 | 0.04 | Why? |
| Fructose | 1 | 2017 | 52 | 0.04 | Why? |
| Pharmacogenomic Variants | 1 | 2017 | 112 | 0.04 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.04 | Why? |
| Linkage Disequilibrium | 1 | 2017 | 191 | 0.04 | Why? |
| Pilot Projects | 2 | 2020 | 5182 | 0.04 | Why? |
| Diplopia | 1 | 2017 | 84 | 0.04 | Why? |
| Ataxia | 1 | 2017 | 133 | 0.04 | Why? |
| Vertigo | 1 | 2017 | 141 | 0.04 | Why? |
| Health Policy | 1 | 2017 | 6242 | 0.04 | Why? |
| Neural Pathways | 1 | 2017 | 155 | 0.04 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.04 | Why? |
| Organizations | 1 | 2018 | 201 | 0.04 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.04 | Why? |
| HLA-A Antigens | 1 | 2017 | 196 | 0.04 | Why? |
| Brain Mapping | 1 | 2017 | 228 | 0.04 | Why? |
| Electric Stimulation Therapy | 1 | 2017 | 151 | 0.04 | Why? |
| Triazines | 1 | 2017 | 246 | 0.04 | Why? |
| Dizziness | 1 | 2017 | 275 | 0.04 | Why? |
| Sodium | 1 | 2017 | 309 | 0.04 | Why? |
| Mental Disorders | 1 | 2018 | 6742 | 0.04 | Why? |
| Consciousness Disorders | 1 | 2017 | 335 | 0.03 | Why? |
| Self-Management | 1 | 2020 | 546 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.03 | Why? |
| Infant, Newborn | 3 | 2020 | 23105 | 0.03 | Why? |
| Remission Induction | 1 | 2017 | 950 | 0.03 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2019 | 53120 | 0.03 | Why? |
| Mood Disorders | 1 | 2017 | 431 | 0.03 | Why? |
| Austria | 1 | 2018 | 1259 | 0.03 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.03 | Why? |
| Dietary Supplements | 1 | 2005 | 2251 | 0.03 | Why? |
| Parenting | 1 | 2018 | 486 | 0.03 | Why? |
| Double-Blind Method | 2 | 2019 | 5988 | 0.03 | Why? |
| Visual Field Tests | 1 | 2012 | 77 | 0.03 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Europe | 2 | 2018 | 12702 | 0.03 | Why? |
| Datasets as Topic | 1 | 2018 | 1404 | 0.03 | Why? |
| Visual Fields | 1 | 2012 | 123 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2017 | 1648 | 0.03 | Why? |
| Pain Management | 1 | 2019 | 854 | 0.03 | Why? |
| Drug Interactions | 1 | 2018 | 1653 | 0.03 | Why? |
| Saliva | 2 | 2017 | 4679 | 0.03 | Why? |
| Learning | 1 | 2017 | 1181 | 0.02 | Why? |
| Mothers | 1 | 2018 | 1624 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Preoperative Care | 1 | 2017 | 1515 | 0.02 | Why? |
| Autopsy | 1 | 2019 | 3495 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Health Personnel | 1 | 2017 | 29646 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2018 | 3803 | 0.02 | Why? |
| Cause of Death | 1 | 2019 | 4823 | 0.02 | Why? |
| Tomography, Optical Coherence | 1 | 2012 | 1008 | 0.02 | Why? |
| International Cooperation | 1 | 2018 | 3436 | 0.02 | Why? |
| Models, Molecular | 1 | 2018 | 7616 | 0.02 | Why? |
| Brazil | 1 | 2021 | 12582 | 0.02 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Germany | 1 | 2018 | 9196 | 0.01 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Italy | 1 | 2018 | 38444 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Chronic Disease | 1 | 2005 | 5139 | 0.01 | Why? |
Sander's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(259)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(108)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_